Should You Retain CAH Stock After Removal From Several Russell Indices?Zacks Investment Research • 07/09/26
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11PRNewsWire • 07/09/26
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy RatingSeeking Alpha • 07/03/26
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-TermZacks Investment Research • 07/02/26
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 06/25/26
Cardinal Health (CAH) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 06/24/26
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?Zacks Investment Research • 06/19/26
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 06/18/26
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?Zacks Investment Research • 06/18/26
Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026PRNewsWire • 06/15/26
Wall Street Analysts Predict a 25.75% Upside in Cardinal (CAH): Here's What You Should KnowZacks Investment Research • 06/01/26
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?Zacks Investment Research • 05/27/26
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?Zacks Investment Research • 05/25/26
Here's Why You Should Add Cardinal Health Stock to Your Portfolio NowZacks Investment Research • 05/20/26